Author:
Gavazzoni Mara,Vizzardi Enrico,Gorga Elio,Bonadei Ivano,Rossi Laura,Belotti Angelo,Rossi Giuseppe,Ribolla Rossella,Metra Marco,Raddino Riccardo
Reference85 articles.
1. SEER Cancer Statistics Review, 1975–2007;Altekruse,2007
2. Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverseevents;Arastu-Kapur;Clin. Cancer Res.,2011
3. Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety;Badros;Leukemia,2013
4. The proteasome inhibitor lactacystin attenuates growth and migration of vascular smooth muscle cells and limits the response to arterial injury;Barringhaus;Exp. Clin. Cardiol.,2007
5. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques;Bennett;J. Clin. Investig.,1995
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献